Literature DB >> 20105199

The impact of cytomegalovirus infection ≥1 year after primary renal transplantation.

Barry J Browne1, Jo-Anne Young, Ty B Dunn, Arthur J Matas.   

Abstract

We studied the impact of a first post-transplant cytomegalovirus (CMV) infection greater than one year after primary kidney transplantation. Risk factors for developing late CMV were acute rejection and donor-recipient CMV status. Of those developing late CMV, 35% were donor (D) positive, recipient (R) negative; however, 23% were D+R+, 22% D-R+, and 15% D-R-. Late CMV was associated with significantly decreased patient and graft survival.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20105199      PMCID： PMC3553593          DOI： 10.1111/j.1399-0012.2010.01208.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN： 0902-0063            Impact factor:   2.863


  20 in total

1.  Late and atypical cytomegalovirus disease in solid-organ transplant recipients.

Authors:  M Slifkin; P Tempesti; D D Poutsiaka; D R Snydman
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  Late-onset cytomegalovirus reactivation in critically ill renal transplant patients.

Authors:  Friederike Jochimsen; Timm Westhoff; Elisabeth Engelmann; Jürgen-Heiner Schäfer; Gerd Offermann; Walter Zidek
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

3.  Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.

Authors:  Supha K Arthurs; Albert J Eid; Rachel A Pedersen; Walter K Kremers; Fernando G Cosio; Robin Patel; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

4.  Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection?

Authors:  C C Linnemann; C R Dunn; M R First; M Alvira; G M Schiff
Journal:  Arch Intern Med       Date:  1978-08

5.  Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

Authors:  Bryan N Becker; Yolanda T Becker; Glen E Leverson; William D Simmons; Hans W Sollinger; John D Pirsch
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

6.  Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.

Authors:  A J Matas; T Ramcharan; S Paraskevas; K J Gillingham; D L Dunn; R W Gruessner; A Humar; R Kandaswamy; J S Najarian; W D Payne; D E Sutherland
Journal:  Am J Transplant       Date:  2001-09       Impact factor: 8.086

7.  Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.

Authors:  Y Boobes; M Al Hakim; H Dastoor; B Bernieh; S Abdulkhalik
Journal:  Transplant Proc       Date:  2004 Jul-Aug       Impact factor: 1.066

8.  Acyclovir in cytomegalovirus infection 3 1/2 years after renal transplantation. An unusual case and dramatic response.

Authors:  P S Barnett; A M Meyers; B D Schoub; S Johnson; J R Botha
Journal:  S Afr Med J       Date:  1984-10-27

9.  Evolution of immunosuppression at the University of Minnesota.

Authors:  A J Matas; D E R Sutherland; J S Najarian
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

10.  Late cytomegalovirus disease following liver transplantation.

Authors:  Oren Shibolet; Yaron Ilan; Yosef Kalish; Rifaat Safadi; Yaffa Ashur; Ahmed Eid; Daniel Shouval; Dana Wolf
Journal:  Transpl Int       Date:  2003-08-05       Impact factor: 3.782
View more
  9 in total

1.  Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients.

Authors:  R U Pliquett; C Klein; T Grünewald; B R Ruf; J Beige
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

2.  A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.

Authors:  Anne-Kristina Frobel; Mats O Karlsson; Janne T Backman; Kalle Hoppu; Erik Qvist; Paula Seikku; Hannu Jalanko; Christer Holmberg; Ron J Keizer; Samuel Fanta; Siv Jönsson
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

3.  IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.

Authors:  Mahmoud Sadeghi; Imad Lahdou; Gerhard Opelz; Arianeb Mehrabi; Martin Zeier; Paul Schnitzler; Volker Daniel
Journal:  BMC Immunol       Date:  2016-10-03       Impact factor: 3.615

4.  Cytomegalovirus Infection after Renal Transplantation: Occurrence, Clinical Features, and the Cutoff for Antigenemia in a University Hospital in Brazil.

Authors:  Sócrates Bezerra de Matos; Roberto Meyer; Fernanda Washington de Mendonça Lima
Journal:  Infect Chemother       Date:  2017-12

5.  Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.

Authors:  Linda A Selvey; Wai H Lim; Peter Boan; Ramyasuda Swaminathan; Claudia Slimings; Amy E Harrison; Aron Chakera
Journal:  BMC Infect Dis       Date:  2017-07-17       Impact factor: 3.090

Review 6.  Very-late-onset cytomegalovirus disease: a case-report and review of the literature.

Authors:  Hania Burgan; Gael Gosteli; Marc Giovannini; Reto Lienhard; Olivier Clerc
Journal:  BMC Res Notes       Date:  2017-06-13

7.  Assessment of Risk Factors and Outcome of Early Versus Late Cytomegalovirus Infection Infection in Living-related D+/R + Renal Allograft Recipients.

Authors:  Atul Srivastava; Soumita Bagchi; Sarman Singh; Veena Balloni; Sanjay Kumar Agarwal
Journal:  Indian J Nephrol       Date:  2021-03-27

8.  CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors.

Authors:  Ambreen Azhar; Makoto Tsujita; Manish Talwar; Vasanthi Balaraman; Anshul Bhalla; James D Eason; Simonne S Nouer; Keiichi Sumida; Adam Remport; Isaac E Hall; Randi Griffin; George Rofaiel; Miklos Z Molnar
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

9.  Murine Cytomegalovirus-induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.

Authors:  Ute Saunders; Mao Li; Srinivasa R Boddeda; Sonya Maher; Jessica Ghere; Irina Kaptsan; Ravi Dhital; Victoria Velazquez; Lingling Guo; Bo Chen; Qiang Zeng; Trenton R Schoeb; Rachel Cianciolo; Masako Shimamura
Journal:  Transplantation       Date:  2021-08-01       Impact factor: 5.385
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.